David Abramian

IV
5papers
231citations
Novelty31%
AI Score23

5 Papers

IVOct 26, 2020Code
What is the best data augmentation for 3D brain tumor segmentation?

Marco Domenico Cirillo, David Abramian, Anders Eklund

Training segmentation networks requires large annotated datasets, which in medical imaging can be hard to obtain. Despite this fact, data augmentation has in our opinion not been fully explored for brain tumor segmentation. In this project we apply different types of data augmentation (flipping, rotation, scaling, brightness adjustment, elastic deformation) when training a standard 3D U-Net, and demonstrate that augmentation significantly improves the network's performance in many cases. Our conclusion is that brightness augmentation and elastic deformation work best, and that combinations of different augmentation techniques do not provide further improvement compared to only using one augmentation technique. Our code is available at https://github.com/mdciri/3D-augmentation-techniques.

IVOct 20, 2021
Evaluation of augmentation methods in classifying autism spectrum disorders from fMRI data with 3D convolutional neural networks

Johan Jönemo, David Abramian, Anders Eklund

Classifying subjects as healthy or diseased using neuroimaging data has gained a lot of attention during the last 10 years. Here we apply deep learning to derivatives from resting state fMRI data, and investigate how different 3D augmentation techniques affect the test accuracy. Specifically, we use resting state derivatives from 1,112 subjects in ABIDE preprocessed to train a 3D convolutional neural network (CNN) to perform the classification. Our results show that augmentation only provide minor improvements to the test accuracy.

CVMar 19, 2020
Vox2Vox: 3D-GAN for Brain Tumour Segmentation

Marco Domenico Cirillo, David Abramian, Anders Eklund

Gliomas are the most common primary brain malignancies, with different degrees of aggressiveness, variable prognosis and various heterogeneous histological sub-regions, i.e., peritumoral edema, necrotic core, enhancing and non-enhancing tumour core. Although brain tumours can easily be detected using multi-modal MRI, accurate tumor segmentation is a challenging task. Hence, using the data provided by the BraTS Challenge 2020, we propose a 3D volume-to-volume Generative Adversarial Network for segmentation of brain tumours. The model, called Vox2Vox, generates realistic segmentation outputs from multi-channel 3D MR images, segmenting the whole, core and enhancing tumor with mean values of 87.20%, 81.14%, and 78.67% as dice scores and 6.44mm, 24.36mm, and 18.95mm for Hausdorff distance 95 percentile for the BraTS testing set after ensembling 10 Vox2Vox models obtained with a 10-fold cross-validation.

IVJul 19, 2019
Generating fMRI volumes from T1-weighted volumes using 3D CycleGAN

David Abramian, Anders Eklund

Registration between an fMRI volume and a T1-weighted volume is challenging, since fMRI volumes contain geometric distortions. Here we present preliminary results showing that 3D CycleGAN can be used to synthesize fMRI volumes from T1-weighted volumes, and vice versa, which can facilitate registration.

CVOct 15, 2018
Refacing: reconstructing anonymized facial features using GANs

David Abramian, Anders Eklund

Anonymization of medical images is necessary for protecting the identity of the test subjects, and is therefore an essential step in data sharing. However, recent developments in deep learning may raise the bar on the amount of distortion that needs to be applied to guarantee anonymity. To test such possibilities, we have applied the novel CycleGAN unsupervised image-to-image translation framework on sagittal slices of T1 MR images, in order to reconstruct facial features from anonymized data. We applied the CycleGAN framework on both face-blurred and face-removed images. Our results show that face blurring may not provide adequate protection against malicious attempts at identifying the subjects, while face removal provides more robust anonymization, but is still partially reversible.